Templewater has announced its acquisition of OncoCare Medical and Novena Heart Centre, leading oncology and cardiology private clinic groups in Singapore.
Information on the Target
Templewater is set to acquire OncoCare Medical ("OncoCare") and Novena Heart Centre ("NHC"), both of which are leading private clinic groups specializing in oncology and cardiology in Singapore. OncoCare, established in 2007, operates a network of seven clinics strategically located within renowned hospitals, providing services from a team of 13 specialized oncologists. The clinic group caters to a diverse patient base that includes both local residents and international clients.
NHC, also founded in 2007, is recognized as one of the largest multi-disciplinary cardiology groups in Singapore, with three advanced clinics situated in prime areas. The team consists of five cardiologists who cover various subspecialties, offering comprehensive inpatient and outpatient cardiology services.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Singapore
Singapore's healthcare sector is renowned for its advanced and efficient medical services, showcasing a blend of public and private healthcare facilities. It has consistently been ranked as one of the top he
Similar Deals
Templewater → TalkMED Group Limited
2025
TBS Energi Utama → Asia Medical Enviro Services
2023
Templewater
invested in
OncoCare Medical and Novena Heart Centre
in 2023
in a Buyout deal